On examination found to have anaemia (HB-7gm%), generalised oedema, proteinuria, hyperproteinaemia, hypertension, raised serum β HCG (4, 24, 249mIU/ml), normal cardiovascular, renal, hepatic and thyroid ABSTRACT Partial molar pregnancy is a rare entity in which there is usually a triploid abnormal foetus associated with a large placenta with cystic changes. The incidence of a normal diploid foetus and a partial molar placenta is extremely rare.
INTRODUCTION
Gestational trophoblastic disease consists of a broad spectrum of conditions ranging from an uncomplicated partial hydatidiform molar pregnancy to stage IV choriocarcinoma with cerebral metastasis. Hydatidiform mole is characterized by abnormal fetoplacental development and trophoblastic hyperplasia, resulting from genetically abnormal conception when there is excessive paternally derived genetic material. It is classified into complete mole when there is total replacement of normal placenta by grossly dilated and hydropic villi in the absence of foetus and the incomplete or partial mole showing partial replacement with hydropic villi and visible abnormal foetal parts leading to termination of the pregnancy in first trimester. Foetus in such cases is rarely alive at the time of diagnosis and often shows gross congenital anomalies associated with triploidy and have a grave prognosis due to limited functional placenta and severe intrauterine foetal growth retardation. 1 Partial molar pregnancy with coexistent live foetus as seen in our case is extremely rare excluding cases of multiple conceptions. Incidence of a normal foetus and partial molar placenta is 0.005 to 0.01% of all pregnancies. 2
CASE REPORT
A 24-year-old primigravida at 20 week 3 days of gestation presented with 3 -4 episodes of vaginal bleeding and generalised swelling of the body since one month. function. P/A Fundal height was more than the period of amenorrhea. USG revealed single live foetus without any structural anomaly and biometry consistent with gestational age of 17 week 2 days. Estimated weight about 170gm (Small for date baby), placenta attached to posterior uterine wall covering internal os, thick (82×171mm) with radioluscent cyst (molar changes). No retro placental clot or separation seen. No evidence of separate normal placenta found. Both ovaries were enlarged (52×68mm, 45×58mm) with thecal lutein cyst. Patient was put on antihypertensive therapy. Severe preeclampsia persisted despite optimal therapy hence a decision to terminate the pregnancy was made. In view of placenta praevia hysterotomy was done and adequate blood transfusion was given. An apparently normal live foetus (approx. 200gm) and placenta (approx. 700gm) with multiple grape like vesicles was evacuated and sent for karyotyping and histopathologic study respectively. Histopathology showed partial molar changes in placenta and karyotyping showed trisomy 21. Serial monitoring of serum β hcg performed monthly for two month showed downward trend with a level of 0.57mIU/ml after 2 months. She was advised barrier contraceptive to avoid pregnancy for at least one year
DISCUSSION
Partial molar pregnancy with coexistent live foetus as seen in our case is extremely rare excluding cases of multiple conceptions. Incidence of a normal foetus and partial molar placenta is 0.005 to 0.01% of all pregnancies. 2 It usually derives from dispermic fertilization of a haploid normal oocyte and produces a triploid set of chromosomes. 3 Such association has been divided into three types. 1 • The first and most common is a twin pregnancy with one normal foetus having a normal placenta and another complete mole.
• Second type is a twin pregnancy with normal foetus and placenta and another partial mole. • The third and most uncommon occurrence is a singleton normal foetus with partial molar placenta.
Such a foetus should have a normal karyotype to survive. Placenta in a partial mole with foetus in a singleton pregnancy results from dispermy and has a triploid karyotype in most cases. 4 Partial molar placenta with coexistent singleton normal foetus with normal karyotype has been reported only seventeen times in extensively searched medical literature. 5 In case of a singleton normal foetus with partial molar placenta, foetal survival depends upon several factors.
• Normal karyotype of the foetus (Sarno et al). 6 • Smaller molar placenta compared to normal placenta (Jones, and Lauersen, Deaten et al). 7 • The onset of molar degeneration and its speed of degeneration (Jones and Lauersan, Sarno et al). 8 • Absence of anaemia occurring in the foetus (Crooij et al). 9 • Absence of maternal complications such as preeclampsia, thyrotoxicosis and vaginal bleeding interrupting the pregnancy (Teng and Ballon). 10 Szulman and Surti et al reported eight cases of partial mole coexisting with the foetus with normal karyotype after 15 gestational weeks, but only two of the infants survived. 11 Parveen Z et al reported a partial hydatidiform mole along with term gestation ended in normal alive and healthy foetus. 12 Pool R et al reported partial mole with coexistent live full term foetus. The pregnancy proceeded to term and ended in the spontaneous vaginal delivery of a normal baby. The placenta showed areas of macroscopic cystic degeneration with the histological features of hydatiform mole. 13 Kajal kiran Dhingra et al reported two cases of singleton pregnancy, in which focal placental molar change was deleted. However, the pregnancy ended in phenotypically normal term foetus. 14 The problems in the management of molar pregnancy and a live foetus involve the risks of foetal abnormality, malignant trophoblastic change, and severe maternal complications such as preeclampsia, thyrotoxicosis, heavy bleeding, pregnancy failure, and preterm birth. Termination of pregnancy might be required due to these complications. Amniocentesis should be done for karyotyping. Our case had partial molar change with live foetus having complication of severe preeclampsia persisted despite optimal therapy hence a decision to terminate the pregnancy was made.
CONCLUSION
In conclusion, partial molar pregnancy with a coexisting live foetus, in addition to chromosomal evaluation and detailed ultrasound examination to exclude foetal abnormality before the decision to postpone intervention, prenatal consultation should include complete discussion of maternal and foetal risks, especially the possible requirement of chemotherapy or even hysterectomy. It is also necessary to have close follow-up and evaluation of the condition of the patient during prenatal and postnatal period.
